Phibro Animal Health Corporation (PAHC)

Operating profit margin

		Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating income	US$ in thousands	110,465	53,315	71,847	46,295	75,961
Revenue	US$ in thousands	1,296,220	1,017,680	977,889	942,300	833,350
Operating profit margin		8.52%	5.24%	7.35%	4.91%	9.12%

June 30, 2025 calculation

Operating profit margin = Operating income ÷ Revenue
= $110,465K ÷ $1,296,220K
= 8.52%

The operating profit margin of Phibro Animal Health Corporation has exhibited noticeable fluctuations over the analyzed period from June 30, 2021, to June 30, 2025.

In the fiscal year ending June 30, 2021, the operating profit margin stood at 9.12%, indicating a relatively robust profitability from operational activities. This margin subsequently declined significantly in the following year to 4.91%, suggesting increased operating costs or pricing pressures that adversely impacted operational efficiency and profitability.

By June 30, 2023, the operating profit margin partially recovered to 7.35%, reflecting some improvement in operational performance, but it remained below the 2021 level. A further decline was observed by June 30, 2024, when the margin decreased to 5.24%, indicating a transient downturn in operational profitability during this period.

In the most recent fiscal year ending June 30, 2025, the operating profit margin increased again to 8.52%. Although this is below the 2021 peak, it represents a notable recovery, potentially signaling improvements in cost management, pricing strategies, or revenue growth initiatives.

Overall, the trend suggests that Phibro Animal Health Corporation's operating profitability has been subject to volatility, with a notable decline from 2021 to 2022, followed by partial recoveries in subsequent years. The shifts may be influenced by external market conditions, cost structures, or strategic adjustments undertaken by the company during this timeframe.